Drug restores kidney cell function in experimental models of rare Lowe syndrome
Over two decades of research into the cellular mechanisms underlying Lowe syndrome have led to the identification of a potential therapeutic strategy for this rare genetic disorder, which affects the eyes, nervous system and kidneys. The findings are described in a study published in Signal Transduction and Targeted Therapy, by the research group led by Antonella De Matteis, coordinator of the…
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
